CYP2B6: Inching towards personalized medicine

被引:0
|
作者
Gogtay, N. J.
机构
关键词
POLYMORPHISM;
D O I
10.4103/0022-3859.105436
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:233 / 234
页数:2
相关论文
共 50 条
  • [1] CYP2B6*6 or Not CYP2B6*6-That Remains a Question for Precision Medicine and Ketamine!
    Cook-Sather, Scott D.
    Adamson, Peter C.
    Li, Jin
    Hakonarson, Hakon
    [J]. ANESTHESIOLOGY, 2016, 125 (06) : 1085 - 1087
  • [2] Meta-analysis of CYP2B6 polymorphism: Clinical evidence towards personalized therapy?
    Ansari, S.
    Duecker, C.
    Brockmoeller, J.
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2019, 392 : S57 - S57
  • [3] THE EXTENT OF INHIBITION AND INDUCTION OF CYP2B6 BY EFAVRIENZ IS CYP2B6 GENOTYPE-DEPENDENT
    Duong, A.
    Gufford, B.
    Masters, A.
    Burgess, K.
    Lu, J.
    Metzger, I.
    Desta, Z.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 : S36 - S36
  • [4] PharmVar GeneFocus: CYP2B6
    Desta, Zeruesenay
    El-Boraie, Ahmed
    Gong, Li
    Somogyi, Andrew A.
    Lauschke, Volker M.
    Dandara, Collet
    Klein, Kathrin
    Miller, Neil A.
    Klein, Teri E.
    Tyndale, Rachel F.
    Whirl-Carrillo, Michelle
    Gaedigk, Andrea
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 110 (01) : 82 - 97
  • [5] Effects of the CYP2B6*6 Allele on Catalytic Properties and Inhibition of CYP2B6 In Vitro: Implication for the Mechanism of Reduced Efavirenz Metabolism and Other CYP2B6 Substrates In Vivo
    Xu, Cong
    Ogburn, Evan T.
    Guo, Yingying
    Desta, Zeruesenay
    [J]. DRUG METABOLISM AND DISPOSITION, 2012, 40 (04) : 717 - 725
  • [6] CYP2B6 allelic variants and non-genetic factors influence CYP2B6 enzyme function
    Mango, Katalin
    Kiss, Adam Ferenc
    Fekete, Ferenc
    Erdos, Reka
    Monostory, Katalin
    [J]. SCIENTIFIC REPORTS, 2022, 12 (01)
  • [7] CYP2B6 allelic variants and non-genetic factors influence CYP2B6 enzyme function
    Katalin Mangó
    Ádám Ferenc Kiss
    Ferenc Fekete
    Réka Erdős
    Katalin Monostory
    [J]. Scientific Reports, 12
  • [8] Bioactivation of chlorpyrifos by CYP2B6 variants
    Crane, Alice L.
    Klein, Kathrin
    Olson, James R.
    [J]. XENOBIOTICA, 2012, 42 (12) : 1255 - 1262
  • [9] Haplotypes frequencies of CYP2B6 in Malaysia
    Musa, N.
    Zulkafli, M., I
    Talib, N.
    Mohamad, N.
    Fauzi, H.
    Ismail, R.
    [J]. JOURNAL OF POSTGRADUATE MEDICINE, 2012, 58 (04) : 235 - 241
  • [10] CYP2B6 GENETIC VARIATION AND EFAVIRENZ AUTOINDUCTION INFLUENCES CYP2B6 A ACTIVITY AND EFAVIRENZ EXPOSURE IN HEALTHY VOLUNTEERS
    Metzger, I. F.
    Lu, J. B.
    Kreutz, Y.
    Thong, N.
    Flockhart, D. A.
    Desta, Z.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 : S80 - S80